MAM
CUE icon

Monaco Asset Management’s Cue Biopharma CUE Stock Holding History

Monaco Asset Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,440
Closed -$314K – 82
2024
Q2 		$314K Sell
8,440
-2,718
-24% -$134K 0.16% 60
2024
Q1 		$633K Sell
11,158
-250
-2% -$17.6K 0.28% 49
2023
Q4 		$904K Sell
11,408
-583
-5% -$41.7K 0.35% 58
2023
Q3 		$827K Sell
11,991
-356
-3% -$34.8K 0.41% 52
2023
Q2 		$1.35M Sell
12,347
-3,198
-21% -$376K 0.73% 45
2023
Q1 		$1.66M Sell
15,545
-1,028
-6% -$98K 0.75% 40
2022
Q4 		$1.42M Buy
16,573
+1,278
+8% +$117K 0.51% 46
2022
Q3 		$1.02M Buy
15,295
+500
+3% +$43K 0.46% 45
2022
Q2 		$1.1M Buy
14,795
+13,295
+886% +$1.56M 0.51% 38
2022
Q1 		$220K Buy
+1,500
New +$318K 0.12% 46

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return